Glofitamab Combined With CAR-T Therapy in R/R DLBCL

Clinical trial NCT07326371 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07326371
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

DLBCL - Diffuse Large B Cell Lymphoma

Start date: 2026-03-01
Primary completion: 2027-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.